Dissecting Aneurysm of Cerebral Artery
5
1
1
0
Key Insights
Highlights
Treatment Research
5 treatments under study, led by Atorvastatin
Research Leaders
20 sponsors active, led by Beijing Neurosurgical Institute
Related Conditions
Often studied with 4 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 5 trials
0%
0 trials in Phase 3/4
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Clinical Trials (5)
Registry of Endovascular Treatment for Vertebrobasilar Dissecting Aneurysms in China
Metformin in Patients With Unruptured Vertebrobasilar Dissecting Aneurysms (METTLE)
Atorvastatin in the TREATment of Intracranial Unruptured VertebroBasilar Dissecting Aneurysms
Dynamic Contrast-Enhanced Magnetic Resonance Imaging Analysis for Prognosis of Intracranial Dissecting Aneurysm With Intramural Hematoma After Endovascular Treatment
Prospective Observation for Serial Changes of Acute Intracranial Artery Dissection Using High Resolution MRI
Research Network
Common Treatments
- Atorvastatin1
- Intracranial Stent Flow Diverter And Coils1
- Metformin1
- High Resolution Magnetic Resonance Imaging For Intracranial Vessel Walls1
- Multidisciplinary Assessment1
Active Sponsors
- Beijing Neurosurgical Institute2
- Xingtai People's Hospital1
- Ministry of Health & Welfare, Korea1
- Yichang Central People's Hospital1
- Beijing Tiantan Hospital1
Top Investigators
Asan Medical Center
Related Conditions
- Cerebral Arterial Diseases1
- Intimal Dissection1
- Intramural Hematomas1
- Inflammation Vascular1